1-3 of 3
Willie Newsome
Close
Sort by
Journal Articles

Phase II Study of Vorinostat in Combination with Idarubicin (Ida) and Cytarabine (ara-C) as Front Line Therapy in Acute Myelogenous Leukemia (AML) or Higher Risk Myelodysplastic Syndrome (MDS).

Guillermo Garcia-Manero, MD, Francesco Paolo Tambaro, MD, PhD, B. Nebiyou Bekele, PhD, Elias Jabbour, MD, Farhad Ravandi, M.D., Hui Yang, MD, PhD, Gautam Borthakur, MD, Tapan Kadia, MD, Jorge Cortes, MD, Stefan Faderl, MD, Marina Konopleva, MD, PhD, Sherry Pierce, RN, Jan A. Burger, MD, PhD, Zeev Estrov, MD, Susan O'Brien, M.D., Deborah Thomas, Willie Newsome, RN, Hagop Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 1055.
https://doi.org/10.1182/blood.V114.22.1055.1055
Published: 2009
Journal Articles

A Phase II Randomized Bayesian Study of Very Low Dose Subcutaneous Decitabine Administered Daily or Weekly Times Three in Patients with Lower Risk Myelodysplastic Syndrome (MDS).

Guillermo Garcia-Manero, MD, Daniel R. Couriel, MD, Francesco Paolo Tambaro, MD, PhD, Nashat Gabrail, Ahmed Nadeem, MD, Tapan Kadia, MD, Elias Jabbour, MD, Gautam Borthakur, MD, Stefan Faderl, MD, Willie Newsome, RN, Hui Yang, MD, PhD, Kevin Chen, Karen Stein, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 119.
https://doi.org/10.1182/blood.V114.22.119.119
Published: 2009
Journal Articles

A Phase I Study of the Combination of the Histone Deacetylase Inhibitor Vorinostat with Idarubicin in Advanced Acute Leukemia.

Tapan M. Kadia, MD, Alessandra Ferrajoli, MD, Farhad Ravandi, MD, Jorge Cortes, MD, Deborah Thomas, MD, William Wierda, MD, PhD, Srdan Verstovsek, MD, Willie Newsome, James Zwiebel, MD, Merrill Egorin, MD, Hagop Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2007) 110 (11): 1842.
https://doi.org/10.1182/blood.V110.11.1842.1842
Published: 2007